Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Phio Pharmaceuticals ( (PHIO) ).
On February 17, 2026, Phio Pharmaceuticals Corp. amended the employment agreement of its President and CEO, Robert J. Bitterman, revising key severance and incentive terms. The change increases his severance to 12 months of base salary if he is terminated without cause or resigns for good reason, aligning his protection with typical biotech executive packages.
The amendment also raises Bitterman’s annual target bonus opportunity to 50% of his base salary from the prior 40% level. The move signals the board’s effort to strengthen executive retention and incentive alignment as the company navigates its ongoing strategic and operational priorities.
The most recent analyst rating on (PHIO) stock is a Buy with a $14.00 price target. To see the full list of analyst forecasts on Phio Pharmaceuticals stock, see the PHIO Stock Forecast page.
Spark’s Take on PHIO Stock
According to Spark, TipRanks’ AI Analyst, PHIO is a Neutral.
The score is held down primarily by weak financial performance (no revenue, continued losses and cash burn) and a bearish technical trend (below major moving averages with negative MACD). Offsetting these are constructive corporate developments for PH-762 (positive Phase 1b data and regulatory progress) and a low-debt balance sheet, but valuation remains challenged due to ongoing losses and no dividend support.
To see Spark’s full report on PHIO stock, click here.
More about Phio Pharmaceuticals
Phio Pharmaceuticals Corp. is a biotechnology company that develops pharmaceutical products, operating in the broader biopharmaceutical industry. The company is led by President and Chief Executive Officer Robert J. Bitterman, whose employment terms and incentives are a focus of its executive compensation structure.
Average Trading Volume: 3,768,664
Technical Sentiment Signal: Sell
Current Market Cap: $17.76M
For an in-depth examination of PHIO stock, go to TipRanks’ Overview page.